These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 2828684

  • 1. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ, Young LS, Calender A, Gregory CD, Rowe M, Lenoir GM, Rickinson AB.
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM.
    Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936
    [Abstract] [Full Text] [Related]

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.
    Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.
    J Virol; 1988 Oct 01; 62(10):3747-55. PubMed ID: 2843672
    [Abstract] [Full Text] [Related]

  • 8. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B, Ehlin-Henriksson B, Klein G, Masucci MG.
    J Virol; 1990 Nov 01; 64(11):5441-7. PubMed ID: 2170681
    [Abstract] [Full Text] [Related]

  • 9. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C, Howe JG, Speck SH, Miller G.
    J Virol; 1989 Apr 01; 63(4):1531-9. PubMed ID: 2538644
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir GM, Bornkamm GW.
    J Virol; 1991 Jan 01; 65(1):415-23. PubMed ID: 1845900
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC.
    PLoS Pathog; 2020 Jun 01; 16(6):e1008590. PubMed ID: 32542010
    [Abstract] [Full Text] [Related]

  • 13. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 01; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 01; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 15. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S, Speck SH, Woisetschläger M.
    J Virol; 1996 Jun 01; 70(6):3561-70. PubMed ID: 8648690
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ, Crawford DH, Griffin BE.
    J Gen Virol; 1989 Jul 01; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [Abstract] [Full Text] [Related]

  • 17. Epstein-barr virus-induced resistance to drugs that activate the mitotic spindle assembly checkpoint in Burkitt's lymphoma cells.
    Leao M, Anderton E, Wade M, Meekings K, Allday MJ.
    J Virol; 2007 Jan 01; 81(1):248-60. PubMed ID: 17035311
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS.
    Blood; 1995 Jul 15; 86(2):659-65. PubMed ID: 7605996
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
    Kempkes B, Zimber-Strobl U, Eissner G, Pawlita M, Falk M, Hammerschmidt W, Bornkamm GW.
    J Gen Virol; 1996 Feb 15; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
    [Abstract] [Full Text] [Related]

  • 20. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG.
    Cancer Surv; 1992 Feb 15; 13():53-80. PubMed ID: 1330300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.